Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 2, Pages -
Publisher
Springer Nature
Online
2019-01-25
DOI
10.1038/s41419-019-1347-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway
- (2018) Chao He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis
- (2017) Ni Li et al. JOURNAL OF CLINICAL INVESTIGATION
- The dark side of SOX2: cancer - a comprehensive overview
- (2017) Erin L. Wuebben et al. Oncotarget
- The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer
- (2017) Richard L. Bennett et al. Cold Spring Harbor Perspectives in Medicine
- The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia
- (2017) Szymon Janczar et al. Cancers
- SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
- (2016) Erin L. Wuebben et al. Oncotarget
- Targeting Apoptosis Pathways in Cancer--Letter
- (2015) S. Safe Cancer Prevention Research
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- SOX2 as prognostic factor in head and neck cancer: a systematic review and meta-analysis
- (2014) Weimin Li et al. ACTA OTO-LARYNGOLOGICA
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness
- (2014) Yajun Tian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway
- (2014) DONG LI et al. Molecular Medicine Reports
- Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation
- (2014) Relja Popovic et al. PLoS Genetics
- SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
- (2013) P. M. Bareiss et al. CANCER RESEARCH
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis
- (2013) Marnie Collins et al. JOURNAL OF CLINICAL ONCOLOGY
- Concise Review: The Sox2-Oct4 Connection: Critical Players in a Much Larger Interdependent Network Integrated at Multiple Levels
- (2013) Angie Rizzino STEM CELLS
- The Emerging Role of SOX2 in Cell Proliferation and Survival and Its Crosstalk with Oncogenic Signaling in Lung Cancer
- (2013) Yu-Ting Chou et al. STEM CELLS
- Prognostic Significance of SOX2 Expression in Nasopharyngeal Carcinoma
- (2012) Xin Wang et al. CANCER INVESTIGATION
- Breast cancer, side population cells and ABCG2 expression
- (2012) K.M. Britton et al. CANCER LETTERS
- Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma
- (2012) Jing Zhang et al. HUMAN PATHOLOGY
- Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
- (2012) Irfan A. Asangani et al. MOLECULAR CELL
- Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3
- (2012) Y. Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
- (2011) Alex J. Kuo et al. MOLECULAR CELL
- Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
- (2011) Daniel Hägerstrand et al. NEURO-ONCOLOGY
- Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas
- (2011) U Basu-Roy et al. ONCOGENE
- SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell
- (2011) X. Jia et al. Journal of Molecular Cell Biology
- Improving RNA-Seq expression estimates by correcting for fragment bias
- (2011) Adam Roberts et al. GENOME BIOLOGY
- Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3
- (2010) Li Ma et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Sox2 Protein Expression is an Independent Poor Prognostic Indicator in Stage I Lung Adenocarcinoma
- (2010) Lynette M. Sholl et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Addition of pamidronate to chemotherapy for the treatment of osteosarcoma
- (2010) Paul A. Meyers et al. CANCER
- Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
- (2009) Susumu Saigusa et al. ANNALS OF SURGICAL ONCOLOGY
- The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate
- (2009) Yan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now